MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
130.84
+4.05
+3.19%
Opening 14:58 05/20 EDT
OPEN
127.98
PREV CLOSE
126.79
HIGH
131.85
LOW
127.81
VOLUME
7.90M
TURNOVER
--
52 WEEK HIGH
139.19
52 WEEK LOW
77.71
TOTAL ASSET
7.59B
YTD YIELD
59.57%
1D
5D
1M
3M
1Y
5Y
1D
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Seeking Alpha · 2d ago
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
Seeking Alpha · 2d ago
Weekly Report: what happened at XBI last week (0511-0515)?
Weekly Report · 2d ago
Strong biopharma dealmaking market set to continue
Seeking Alpha · 6d ago
XBI, APLS, TGTX, TVTX: Large Inflows Detected at ETF
NASDAQ · 6d ago
Why I Now Favor A Barbell Model Over Ray Dalio's All-Weather Portfolio
Seeking Alpha · 05/12 17:46
Taiwan Semiconductor, Freeport-McMoRan And More On CNBC's 'Final Trades'
Benzinga · 05/12 12:28
Analysts Predict 10% Gains Ahead For PSTR
NASDAQ · 05/12 10:48
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 TR USD
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider